Impact of single-dose nandrolone decanoate on gonadotropins, blood lipids and HMG CoA reductase in healthy men

被引:9
作者
Garevik, N. [1 ]
Borjesson, A. [1 ]
Choong, E. [1 ]
Ekstrom, L. [1 ]
Lehtihet, M. [2 ,3 ]
机构
[1] Karolinska Inst, Karolinska Univ Hosp, Div Clin Pharmacol, Dept Lab Med Huddinge, Huddinge, Sweden
[2] Karolinska Inst, Dept Med Huddinge, C2 84, SE-14186 Huddinge, Sweden
[3] Karolinska Univ Hosp, Ctr Androl & Sexual Med, C2 84, SE-14186 Huddinge, Sweden
关键词
Blood lipids; gonadotropins; HMG CoA reductase; nandrolone decanoate; STEROID-INDUCED HYPOGONADISM; GENE-EXPRESSION; ANDROGEN; TESTOSTERONE; CHOLESTEROL; ABUSE; LIPOPROTEIN; RECEPTOR; SERUM;
D O I
10.1111/and.12488
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
The aim was to study the effect and time profile of a single dose of nandrolone decanoate (ND) on gonadotropins, blood lipids and HMG CoA reductase [3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGCR)] in healthy men. Eleven healthy male participants aged 29-46years were given a single dose of 150mg ND as an intramuscular dose of Deca Durabol (R), Organon. Blood samples for sex hormones, lipids and HMGCR mRNA analysis were collected prior to ND administration day 0, 4 and 14. A significant suppression of luteinising hormone (LH) and follicle-stimulating hormone (FSH) was seen after 4days. Total testosterone and bioavailable testosterone level decreased significantly throughout the observed study period. A small but significant decrease in sexual hormone-binding globulin (SHBG) was seen after 4days but not after 14days. Total serum (S)-cholesterol and plasma (P)-apolipoprotein B (ApoB) increased significantly after 14days. In 80% of the individuals, the HMGCR mRNA level was increased 4days after the ND administration. Our results show that a single dose of 150mg ND increases (1) HMGCR mRNA expression, (2) total S-cholesterol and (3) P-ApoB level. The long-term consequences on cardiovascular risk that may appear in users remain to be elucidated.
引用
收藏
页码:595 / 600
页数:6
相关论文
共 37 条
  • [1] Impact of Nandrolone Decanoate on Gene Expression in Endocrine Systems Related to the Adverse Effects of Anabolic Androgenic Steroids
    Alsio, Johan
    Birgner, Carolina
    Bjorkblom, Lars
    Isaksson, Pernilla
    Bergstrom, Lena
    Schioth, Helgi B.
    Lindblom, Jonas
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 (05) : 307 - 314
  • [2] Pharmacokinetic evaluation of three different intramuscular doses of nandrolone decanoate: Analysis of serum and urine samples in healthy men
    Bagchus, WM
    Smeets, JMW
    Verheul, HAM
    De Jager-Van der Veen, SM
    Port, A
    Geurts, TBP
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (05) : 2624 - 2630
  • [3] Anabolic-androgenic steroid therapy in the treatment of chronic diseases
    Basaria, S
    Wahlstrom, JT
    Dobs, AS
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (11) : 5108 - 5117
  • [4] INFLUENCE OF NANDROLONDECANOATE ON THE PITUITARY-GONADAL AXIS IN MALES
    BIJLSMA, JWJ
    DUURSMA, SA
    THIJSSEN, JHH
    HUBER, O
    [J]. ACTA ENDOCRINOLOGICA, 1982, 101 (01): : 108 - 112
  • [5] Effects of testosterone and nandrolone on cardiac function: a randomized, placebo-controlled study
    Chung, T.
    Kelleher, S.
    Liu, P. Y.
    Conway, A. J.
    Kritharides, L.
    Handelsman, D. J.
    [J]. CLINICAL ENDOCRINOLOGY, 2007, 66 (02) : 235 - 245
  • [6] Lipoprotein (a) and cholesterol in body builders using anabolic androgenic steroids
    Cohen, LI
    Hartford, CG
    Rogers, GG
    [J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1996, 28 (02) : 176 - 179
  • [7] Anabolic Steroid Induced Hypogonadism in Young Men
    Coward, Robert M.
    Rajanahally, Saneal
    Kovac, Jason R.
    Smith, Ryan P.
    Pastuszak, Alexander W.
    Lipshultz, Larry I.
    [J]. JOURNAL OF UROLOGY, 2013, 190 (06) : 2200 - 2205
  • [8] Anabolic steroids and male infertility: a comprehensive review
    de Souza, Guilherme Leme
    Hallak, Jorge
    [J]. BJU INTERNATIONAL, 2011, 108 (11) : 1860 - 1865
  • [9] DEVISSER J, 1960, ACTA ENDOCRINOL-COP, V35, P405
  • [10] The Response to Gonadotropin-Releasing Hormone and hCG in Men with Prior Chronic Androgen Steroid Abuse and Clinical Hypogonadism
    Flanagan, J. N.
    Lehtihet, M.
    [J]. HORMONE AND METABOLIC RESEARCH, 2015, 47 (09) : 668 - 673